Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

325
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
325
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

990
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
990
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

429
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
429
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

269
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
269
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

291
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
291
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

404
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
404

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SYNTAX score for assessing coronary artery disease burden and complexity: past, present, and future.

Revista espanola de cardiologia (English ed.)·2026
Same author

Development of an optimised method for the analysis of human blood plasma samples by atmospheric solids analysis probe mass spectrometry.

International journal of mass spectrometry·2026
Same author

Histological validation of artificial intelligence-driven automatic plaque characterization in coronary OCT: a head-to-head comparison with clinicians.

Cardiology plus·2026
Same author

Integrated Coronary CT Angiography Assessment of Plaque Vulnerability and Clinical Outcomes: The Morphology-Inflammation-Burden (MIB) Score.

JACC. Cardiovascular imaging·2026
Same author

Coronary sinus reducer implantation for refractory angina: a national audit of UK practice.

Heart (British Cardiac Society)·2026
Same author

Pathophysiology, prevention, and management of coronary microvascular obstruction.

European heart journal·2026

Related Experiment Video

Updated: Jan 31, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.7K

Assessing and managing coronary microcirculation dysfunction in acute ST-segment elevation myocardial infarction.

Richard Armstrong1, Giovanni Luigi De Maria2, Roberto Scarsini2

  • 1a Department of Cardiology , St James's Hospital , Dublin , Ireland.

Expert Review of Cardiovascular Therapy
|December 21, 2018
PubMed
Summary

Assessing and managing microvascular dysfunction after ST-segment elevation myocardial infarction (STEMI) is crucial for long-term outcomes. This review covers current evidence and strategies for prevention and treatment to improve patient prognosis.

Keywords:
Coronary angiographycoronary microcirculationinvasive physiologymicrovascular dysfunctionmicrovascular therapymyocardial infarction

More Related Videos

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

12.1K
Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.5K

Related Experiment Videos

Last Updated: Jan 31, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.7K
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

12.1K
Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.5K

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Interventional Cardiology

Background:

  • Microvascular dysfunction in ST-segment elevation myocardial infarction (STEMI) correlates with poor prognosis.
  • Early assessment and intervention can improve outcomes post-primary percutaneous intervention.
  • Coronary microcirculatory impairment is a significant concern in STEMI patients.

Purpose of the Study:

  • To comprehensively review evidence on assessing and managing coronary microcirculatory injury/dysfunction in STEMI.
  • To explore strategies for applying existing and novel therapies for microvascular impairment.
  • To guide clinical practice in preventing and treating microvascular dysfunction.

Main Methods:

  • Review of existing literature on microvascular dysfunction in STEMI.
  • Analysis of non-invasive and invasive assessment methods.
  • Evaluation of pharmacological and mechanical therapeutic strategies.

Main Results:

  • Multiple methods exist for assessing microvascular dysfunction, including invasive physiological measurements with prognostic value.
  • Various therapeutic options, both pharmacological and mechanical, are available for prevention and treatment.
  • Current guidelines lack a clear algorithm for applying these therapies.

Conclusions:

  • Effective assessment of microvascular dysfunction is possible using established methods.
  • Therapeutic strategies for microvascular dysfunction exist but require better clinical guidance.
  • Future research should focus on physiology-guided therapies to identify high-risk STEMI patients benefiting from intervention.